NFKB1 and lung adenocarcinoma: We show that this MPE-promoting phenotype of lung adenocarcinoma, heavily dependent on NF-κB-controlled gene expression and not on NF-κB-independent tumor growth [12-15], can be selectively targeted by tailored proteasome inhibition.